The use of PET/CT in pregnancy: A case report of malignant parathyroid carcinoma and a review of the literature

Abstract

Positron emission tomography scanning is not commonly performed in pregnancy but can be done if required. Fetal doses of radiation can be minimized, and our case exemplifies the safe application of positron emission tomography/computed tomography in pregnancy. A 38-year-old woman in her first ongoing pregnancy presented at 28 weeks’ gestation with symptomatic hypercalcemia. Given a history of parathyroid carcinoma, recurrence was suspected. Ultrasound and magnetic resonance imaging failed to locate the lesion. However, positron emission tomography/computed tomography identified a culprit supraclavicular lymph node. This was excised under local anesthesia resulting in normalization of parathyroid hormone and calcium levels. A term, healthy baby was delivered. The literature provides support that the use of positron emission tomography/computed tomography is acceptable when indicated, and there are modifications to protocols that can further limit risk.

Keywords

Pregnancy positron emission tomography FDG malignancy hypercalcemia parathyroid

Get full access to this article

View all access options for this article.

References

Committee Opinion No. 656: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol 2016; 127: e75–e80.

Stabin

. Proposed addendum to previously published fetal dose estimate tables for 18F-FDG. J Nucl Med 2004; 45: 634–635.

Felmlee

Gray

Leetzow

et al.

Estimated fetal radiation dose from multislice CT studies. AJR Am J Roentgenol 1990; 154: 185–190.

The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007; 37: 1–332.

ICRP Publication 105. Radiation protection in medicine. Ann ICRP 2007; 37: 1–63.

Towson

Fulham

Eberl

et al.

Radiation dose from F18-FDG PET-CT scans in pregnancy. J Nucl Med 2004; 31: s233– s233.

Zanotti-Fregonara

Champion

Trebossen

et al.

Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy. J Nucl Med 2008; 49: 679–682.

Zanotti-Fregonara

Jan

Champion

et al.

In vivo quantification of 18F-FDG uptake in human placenta during early pregnancy. Health Phys 2009; 97: 82–85.

Zanotti-Fregonara

Jan

Taieb

et al.

Absorbed 18F-FDG dose to the fetus during early pregnancy. J Nucl Med 2010; 51: 803–805.

10.

Takalkar

Khandelwal

Lokitz

et al.

18F-FDG PET in pregnancy and fetal radiation dose estimates. J Nucl Med 2011; 52: 1035–1040.

11.

Zanotti-Fregonara

Koroscil

Mantil

et al.

Radiation dose to the fetus from [(18)F]-FDG administration during the second trimester of pregnancy. Health Phys 2012; 102: 217–219.

12.

Hsieh

Sun

et al.

FDG PET/CT of a late-term pregnant woman with breast cancer. Clin Nucl Med 2012; 37: 489–491.

13.

Calais

Hapdey

Tilly

et al.

Hodgkin’s disease staging by FDG PET/CT in a pregnant woman. Nucl Med Mol Imaging 2014; 48: 244–246.

14.

Zanotti-Fregonara

Laforest

Wallis

. Fetal radiation dose from 18F-FDG in pregnant patients imaged with PET, PET/CT, and PET/MR. J Nucl Med 2015; 56: 1218–1222.

15.

Roedler HD, Kaul A, Berner W, et al. Development of an extended formalism for internal dose calculation and for practical application to several biologically distributed radioelements. In: Assessment of radioactive contamination in man. Proceedings of a symposium on assessment of radioactive organ and body burdens, Stockholm, Sweden, 22–26 November, 1971, 1972, pp. 515–540. Vienna, Austria: International Atomic Energy Agency

16.

Kaul

Henrichs

Roedler

. Radionuclide biokinetics and internal dosimetry in nuclear medicine. Ric Clin Lab 1980; 10: 629–660.

17.

Loevinger R. The MIRD perspective. In: Adelstein S, Kassis A and Burt R (eds), Dosimetry of administered radionuclides, Washington, DC, 21–22 September 1989, pp. 29–43. Washington, DC: American College of Nuclear Physicians/Department of Energy.

18.

Howell

Wessels

Loevinger

et al.

The MIRD perspective 1999. Medical Internal Radiation Dose Committee. J Nucl Med 1999; 40: 3s–10s.